Ritchie Lab - Efavirenz pharmacogenetics and weight gain following switch to integrase inhibitor

Leonard, M. A., Cindi, Z., Bradford, Y., Bourgi, K., Koethe, J., Turner, M., Norwood, J., Woodward, B., Erdem, H., Basham, R., Baker, P., Rebeiro, P. F., Sterling, T. R., Hulgan, T., Daar, E. S., Gulick, R., Riddler, S. A., Sinxadi, P., Ritchie, M. D., & Haas, D. W. (2020). Efavirenz pharmacogenetics and weight gain following switch to integrase inhibitor–containing regimens. Clinical Infectious Diseases, 73(7). https://doi.org/10.1093/cid/ciaa1219